Search Browse Earnings

NeuroSense Therapeutics Ltd.

Nasdaq:NRSNNasdaq:NRSNW

Pharmaceutical Preparations·HERZLIYA, L3

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

NeuroSense Therapeutics Ltd. — SlamSEC

Revenue

—

Adj. EBITDA

-$10.5M

FY 2024

Net Income

-$10.5M

FY 2024

EPS (Diluted)

-$0.91

FY 2024

Stock Price

$0.87

+1.4%

2026-03-06

52W Range

$0.68 – $2.60

P/E Ratio

-1.0x

Market Cap

$20.1M

Cash

$2.6M

FY 2024

Total Debt

—

Net Cash

$2.6M

Enterprise Value

$17.5M

Debt / EBITDA

0.3x

FY 2024

EV / EBITDA

-1.7x

Employees

—